Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1996 2
1999 1
2001 1
2002 2
2003 5
2004 2
2005 3
2006 1
2008 1
2009 2
2010 2
2011 1
2013 2
2014 3
2015 1
2016 2
2017 1
2018 2
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
The clinical pharmacokinetics of darifenacin.
Skerjanec A. Skerjanec A. Clin Pharmacokinet. 2006;45(4):325-50. doi: 10.2165/00003088-200645040-00001. Clin Pharmacokinet. 2006. PMID: 16584282 Review.
GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes.
von Richter O, Skerjanec A, Afonso M, Sanguino Heinrich S, Poetzl J, Woehling H, Velinova M, Koch A, Kollins D, Macke L, Wuerth G. von Richter O, et al. Among authors: skerjanec a. Br J Clin Pharmacol. 2017 Apr;83(4):732-741. doi: 10.1111/bcp.13170. Epub 2016 Dec 16. Br J Clin Pharmacol. 2017. PMID: 27790726 Free PMC article. Clinical Trial.
Effect of age on the pharmacokinetics of duloxetine in women.
Skinner MH, Kuan HY, Skerjanec A, Seger ME, Heathman M, O'Brien L, Reddy S, Knadler MP. Skinner MH, et al. Among authors: skerjanec a. Br J Clin Pharmacol. 2004 Jan;57(1):54-61. doi: 10.1046/j.1365-2125.2003.01963.x. Br J Clin Pharmacol. 2004. PMID: 14678340 Free PMC article. Clinical Trial.
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologics.
Bellon A, Wang J, Skerjanec A, Velinova M, Dickerson D, Sabet A, Ngo L, O'Reilly T, Tomek C, Schussler S, Schier-Mumzhiu S, Gattu S, Koch SD, Schelcher C, Dobreva M, Boldea A, Nakov R, Otto GP. Bellon A, et al. Among authors: skerjanec a. Br J Clin Pharmacol. 2020 Jun;86(6):1139-1149. doi: 10.1111/bcp.14226. Epub 2020 Feb 21. Br J Clin Pharmacol. 2020. PMID: 32022282 Free PMC article. Clinical Trial.
38 results